Nadczynność tarczycy
Rokowania, prognozy i postęp choroby

Nadczynność tarczycy, mimo skutecznych metod leczenia, wiąże się z istotnym ryzykiem powikłań, które wpływają na długoterminowe rokowanie. Nieleczona lub źle kontrolowana choroba skraca oczekiwaną długość życia o około 3,1-3,5 lat, głównie z powodu zwiększonego ryzyka chorób sercowo-naczyniowych, takich jak przerost lewej komory, niewydolność serca i migotanie przedsionków. Ponadto, nadczynność tarczycy zwiększa ryzyko wystąpienia nowotworów o 12% (SHR: 1,12; 95% CI: 1,10-1,14), ze szczególnym uwzględnieniem raka płuc (SHR: 1,20), prostaty (SHR: 1,10) i piersi (SHR: 1,07). Powikłania takie jak osteoporoza, udar niedokrwienny, niepłodność oraz oftalmopatia tarczycowa w chorobie Gravesa-Basedowa wymagają stałej kontroli klinicznej. Burza tarczycowa, choć rzadka, stanowi stan zagrożenia życia z 16% śmiertelnością i wymaga natychmiastowej interwencji.

Prognostyka nadczynności tarczycy (Hyperthyroidism Prognosis)

Nadczynność tarczycy (hyperthyroidism) jest stanem, który podlega skutecznemu leczeniu, jednak niesie ze sobą określone czynniki ryzyka mogące wpływać na długoterminowe rokowanie. Prawidłowo leczona nadczynność tarczycy pozwala na utrzymanie prawidłowej jakości życia, natomiast nieleczona bądź źle kontrolowana może prowadzić do poważnych powikłań zdrowotnych.12

Oczekiwana długość życia

Badania wskazują, że nadczynność tarczycy może skracać oczekiwaną długość życia o około 3,1-3,5 lat w porównaniu z osobami bez tej choroby. Wynika to głównie z podwyższonego ryzyka chorób współistniejących, szczególnie sercowo-naczyniowych, które są najczęstszą przyczyną zgonu u pacjentów z nadczynnością tarczycy.34

Starsze badania z 2016 roku raportują zwiększone ryzyko zgonu z różnych przyczyn u osób z nadczynnością tarczycy, przy czym niewydolność serca stanowi główną przyczynę sercowo-naczyniową.5 Nadczynność tarczycy prowadzi do przerostu lewej komory serca, co wiąże się ze zwiększonym ryzykiem niewydolności serca i zgonu z przyczyn kardiologicznych.6

Ryzyko nowotworów

Duże duńskie badanie rejestrowe wykazało zwiększone ryzyko nowotworów u pacjentów z nadczynnością tarczycy. Badanie to wskazuje na 12% wyższe ryzyko wystąpienia wszystkich nowotworów u osób z nadczynnością tarczycy (SHR: 1,12; 95% CI: 1,10-1,14). Szczególnie podwyższone ryzyko dotyczyło:789

  • Raka płuc (SHR: 1,20; 95% CI: 1,16-1,26)
  • Raka prostaty (SHR: 1,10; 95% CI: 1,02-1,19)
  • Raka piersi (SHR: 1,07; 95% CI: 1,02-1,13)

1011

W badanej populacji nowotwory zdiagnozowano u 18,5% osób z nadczynnością tarczycy w porównaniu do 16,5% osób z grupy referencyjnej. Choć wyniki te są statystycznie istotne, autorzy badania zaznaczają, że związek przyczynowo-skutkowy między nadczynnością tarczycy a zwiększonym ryzykiem nowotworów wymaga dalszych badań.1213

Powikłania nieleczonej nadczynności tarczycy

Nieleczona lub nieadekwatnie leczona nadczynność tarczycy może prowadzić do następujących powikłań:1415

  • Migotanie przedsionków (atrial fibrillation) zwiększające ryzyko powikłań zakrzepowo-zatorowych
  • Zastoinowa niewydolność serca
  • Niepłodność
  • Udar niedokrwienny
  • Osteoporoza – zwiększone tempo resorpcji kostnej prowadzi do utraty masy kostnej, szczególnie istotnej u kobiet po menopauzie
  • Oftalmopatia tarczycowa (w chorobie Gravesa-Basedowa)

161718

Przebieg burzy tarczycowej

Burza tarczycowa (thyroid storm, przełom tarczycowy) stanowi rzadkie, ale zagrażające życiu powikłanie nadczynności tarczycy. Charakteryzuje się nagłym uwolnieniem dużej ilości hormonów tarczycy w krótkim czasie. Śmiertelność w przypadku burzy tarczycowej wynosi około 16%, co podkreśla wagę natychmiastowego leczenia tego stanu.1920

Czynniki wyzwalające burzę tarczycową obejmują:21

  • Infekcje
  • Urazy
  • Zabiegi chirurgiczne
  • Nieadekwatne lub przerwane leczenie nadczynności tarczycy

22

Skuteczność metod leczenia i ich wpływ na rokowanie

Terapia jodem radioaktywnym (RAI)

Leczenie jodem promieniotwórczym (I-131) jest skuteczną metodą leczenia nadczynności tarczycy. Badania wskazują na 83% skuteczność terapii RAI, definiowaną jako osiągnięcie stanu eutyreozy lub niedoczynności tarczycy. Tylko 17% pacjentów doświadcza niepowodzenia terapii, a jedynie 9% wymaga powtórzenia terapii RAI.2324

Należy zauważyć, że większość pacjentów (70,8%) po skutecznym leczeniu RAI rozwija niedoczynność tarczycy, a tylko 6,7% osiąga stan eutyreozy. Jednak niedoczynność tarczycy jest łatwiejsza w leczeniu i powoduje mniej długoterminowych problemów zdrowotnych niż nadczynność.2526

Rokowanie w chorobie Gravesa-Basedowa

Choroba Gravesa-Basedowa, jako najczęstsza przyczyna nadczynności tarczycy, ma zazwyczaj dobre rokowanie dzięki skuteczności dostępnych metod leczenia. Leki przeciwtarczycowe pozwalają na kontrolę poziomów hormonów tarczycowych w prawie wszystkich przypadkach, mimo że sama choroba nie ma leczenia przyczynowego.2728

Badania wskazują na różnorodny przebieg kliniczny choroby Gravesa-Basedowa:29

30

Czynniki ryzyka progresji do jawnej nadczynności obejmują starszy wiek pacjenta oraz obecność przeciwciał przeciwko peroksydazie tarczycowej (anty-TPO).31

Czynniki genetyczne a rokowanie

Badania wskazują na silny komponent genetyczny (60-80%) w podatności na chorobę Gravesa-Basedowa. Zidentyfikowano ponad 80 loci podatności genetycznej. Obecność określonych wariantów genetycznych może być związana nie tylko z fenotypem klinicznym, ale także z rokowaniem i ryzykiem nawrotu choroby.3233

Dodanie markerów genetycznych ryzyka w regionie HLA (DRB1-03, DQA1-05, DQB1-02) oraz PTPN22 (rs2476601) do tzw. skali GREAT+ zwiększa wartość predykcyjną nawrotu choroby w porównaniu do uwzględnienia jedynie czynników klinicznych.34

Genotypowanie pacjentów z chorobą Gravesa-Basedowa może mieć znaczny potencjał translacyjny, umożliwiając spersonalizowany plan leczenia i przyszłe wdrożenie nowych terapii immunomodulujących dla odpowiednich pacjentów.35

Rokowanie w wolu guzkowym toksycznym

Nadczynność tarczycy spowodowana toksycznym wolem guzkowym lub gruczolakiem toksycznym ma charakter trwały i zwykle występuje u dorosłych. Po normalizacji funkcji tarczycy za pomocą leków przeciwtarczycowych, zwykle zaleca się ablację jodem radioaktywnym jako terapię definitywną. Nie zaleca się długotrwałego stosowania wysokich dawek leków przeciwtarczycowych.36

Toksyczne wole guzkowe i gruczolaki toksyczne prawdopodobnie będą nadal powoli rosnąć podczas farmakoterapii przeciwtarczycowej. Po terapii jodem radioaktywnym obszary tyreotoksyczne ulegają ablacji, a pacjenci mogą pozostać w stanie eutyreozy. Osoby, u których rozwinie się niedoczynność tarczycy po terapii RAI, są łatwo utrzymywane na terapii zastępczej hormonami tarczycy, z tyroksyną (T4) przyjmowaną raz dziennie.37

Długoterminowe powikłania i monitorowanie

Powikłania sercowo-naczyniowe

Nadmiar hormonów tarczycy powoduje przerost lewej komory, który wiąże się ze zwiększonym ryzykiem niewydolności serca i zgonu z przyczyn kardiologicznych. Tyreotoksykoza była związana z:38

  • Kardiomiopatią rozstrzeniową
  • Niewydolnością prawej komory z nadciśnieniem płucnym
  • Dysfunkcją rozkurczową
  • Migotaniem przedsionków

39

Te powikłania sercowo-naczyniowe stanowią istotne czynniki wpływające na rokowanie długoterminowe u pacjentów z nadczynnością tarczycy, szczególnie u osób starszych.4041

Powikłania kostne

W nadczynności tarczycy obserwuje się zwiększone tempo resorpcji kostnej. Utrata masy kostnej, mierzona za pomocą densytometrii mineralnej kości, może być widoczna w ciężkiej nadczynności tarczycy we wszystkich grupach wiekowych i u obu płci. Jednak w łagodnej subklinicznej chorobie utrata kości została przekonująco wykazana tylko u kobiet po menopauzie.42

Osteoporoza jako długoterminowe powikłanie nadczynności tarczycy może znacząco wpływać na jakość życia pacjentów i zwiększać ryzyko złamań, zwłaszcza u kobiet w starszym wieku.4344

Oftalmopatia w chorobie Gravesa-Basedowa

Pacjenci z chorobą Gravesa-Basedowa mogą rozwinąć niedoczynność tarczycy w naturalnym przebiegu swojej choroby, niezależnie od tego, czy leczenie obejmuje jod radioaktywny czy operację. Choroby oczu mogą rozwinąć się w czasie odległym od początkowej diagnozy i terapii. Generalnie po postawieniu diagnozy oftalmopatia powoli poprawia się w ciągu lat.45

Oftalmopatia tarczycowa stanowi jedno z najbardziej charakterystycznych i potencjalnie upośledzających manifestacji choroby Gravesa-Basedowa, wpływających na jakość życia pacjentów.46

Monitorowanie pacjentów

Ze względu na możliwość długoterminowych powikłań, pacjenci z nadczynnością tarczycy wymagają regularnego monitorowania, nawet po osiągnięciu skutecznej kontroli choroby. Monitorowanie powinno obejmować:4748

  • Regularne badanie poziomów hormonów tarczycy (TSH, fT3, fT4)
  • Ocenę funkcji sercowo-naczyniowej
  • Monitorowanie gęstości mineralnej kości, szczególnie u kobiet po menopauzie
  • Regularne badania okulistyczne u pacjentów z chorobą Gravesa-Basedowa
  • Obserwację pod kątem rozwoju chorób nowotworowych

4950

Podsumowanie rokowania

Rokowanie w nadczynności tarczycy jest generalnie korzystne przy zastosowaniu odpowiedniego leczenia. Większość pacjentów odpowiada dobrze na leczenie, niezależnie od zastosowanej metody terapeutycznej (farmakoterapia, terapia jodem radioaktywnym lub leczenie chirurgiczne).5152

Główne czynniki wpływające na długoterminowe rokowanie obejmują:5354

  • Wczesne rozpoznanie i rozpoczęcie leczenia
  • Predyspozycje genetyczne, szczególnie w chorobie Gravesa-Basedowa
  • Rozwój powikłań sercowo-naczyniowych
  • Przestrzeganie zaleceń terapeutycznych przez pacjenta
  • Regularne monitorowanie i kontrola lekarska

5556

Pomimo ogólnie dobrego rokowania, pacjenci z nadczynnością tarczycy mają skróconą oczekiwaną długość życia o 3,1-3,5 lat w porównaniu z populacją ogólną, co podkreśla znaczenie adekwatnego leczenia i regularnego monitorowania, a także kontroli czynników ryzyka sercowo-naczyniowego.5758

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #2 Hyperthyroidism | Graves’ Disease | Overactive Thyroid | MedlinePlus
    https://medlineplus.gov/hyperthyroidism.html
    Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. […] If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help. […] If hyperthyroidism isn’t treated, it can cause some serious health problems, including: An irregular heartbeat that can lead to blood clots, stroke, heart failure, and other heart problems. […] Almost everyone who has radioactive iodine treatment later develops hypothyroidism. This is because the thyroid hormone-producing cells have been destroyed. But hypothyroidism is easier to treat and causes fewer long-term health problems than hyperthyroidism.
  • #3 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    People with hyperthyroidism have a higher risk of developing further serious health conditions, such as cardiovascular and kidney disease. A persons life expectancy may depend on whether and how they develop those conditions. […] If an individual with the condition does not have serious complications, treatment is effective in managing symptoms and producing positive outcomes. In contrast, people who develop a rare complication known as thyroid storm have a death rate of about 16%. […] Data on the exact life expectancy of someone with hyperthyroidism are not available. That said, a 2017 study suggests that it is 3.1 to 3.5 years shorter than those without the condition. […] Evidence indicates that people with hyperthyroidism have a higher risk of noncommunicable conditions. As these illnesses are serious, they can affect life expectancy.
  • #4 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #5 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #6 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #7 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Cancer is the second most common cause of death worldwide. It is currently debated whether thyroid dysfunction is a modifiable cancer risk factor. Our aim was to evaluate the risk of cancer in patients with hyperthyroidism. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population.
  • #8 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Overall, irrespective of cause of hyperthyroidism and location of cancer, hyperthyroid patients had an increased risk of cancer (SHR: 1.13; 95% CI: 1.12-1.16). […] After adjusting for pre-existing morbidity, patients with hyperthyroidism (SHR: 1.16; 95% CI: 1.14-1.18), GD (SHR: 1.08; 95% CI: 1.05-1.11), and TNG (SHR: 1.19; 95% CI: 1.16-1.23) had an increased risk of cancer. […] In conclusion, this nationwide register-based data demonstrated a 12% increased risk of cancer in a large cohort of hyperthyroid patients. The risk depended on the type of cancer, with increased SHRs for prostate, breast, and lung cancer but not for colorectal cancer. Similar results were found when stratifying for cause of hyperthyroidism. Although the validity of our results is supported by the size of the study it remains to be proven that hyperthyroidism is a pro-cancerogenic condition.
  • #9 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study in: European Thyroid Journal Volume 13 Issue 2 (2024)
    https://etj.bioscientifica.com/view/journals/etj/13/2/ETJ-23-0181.xml
    In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population. The frequency and risk of cancer are summarized in Table 2. Overall, irrespective of cause of hyperthyroidism and location of cancer, hyperthyroid patients had an increased risk of cancer (SHR: 1.13; 95% CI: 1.12-1.16). Almost similar risk estimates were achieved after adjusting for pre-existing morbidity (SHR: 1.12; 95% CI: 1.10-1.14).
  • #10 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Cancer is the second most common cause of death worldwide. It is currently debated whether thyroid dysfunction is a modifiable cancer risk factor. Our aim was to evaluate the risk of cancer in patients with hyperthyroidism. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population.
  • #11 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study in: European Thyroid Journal Volume 13 Issue 2 (2024)
    https://etj.bioscientifica.com/view/journals/etj/13/2/ETJ-23-0181.xml
    In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population. The frequency and risk of cancer are summarized in Table 2. Overall, irrespective of cause of hyperthyroidism and location of cancer, hyperthyroid patients had an increased risk of cancer (SHR: 1.13; 95% CI: 1.12-1.16). Almost similar risk estimates were achieved after adjusting for pre-existing morbidity (SHR: 1.12; 95% CI: 1.10-1.14).
  • #12 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Cancer is the second most common cause of death worldwide. It is currently debated whether thyroid dysfunction is a modifiable cancer risk factor. Our aim was to evaluate the risk of cancer in patients with hyperthyroidism. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population.
  • #13 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study in: European Thyroid Journal Volume 13 Issue 2 (2024)
    https://etj.bioscientifica.com/view/journals/etj/13/2/ETJ-23-0181.xml
    In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population. The frequency and risk of cancer are summarized in Table 2. Overall, irrespective of cause of hyperthyroidism and location of cancer, hyperthyroid patients had an increased risk of cancer (SHR: 1.13; 95% CI: 1.12-1.16). Almost similar risk estimates were achieved after adjusting for pre-existing morbidity (SHR: 1.12; 95% CI: 1.10-1.14).
  • #14 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #15 Hyperthyroidism | Graves’ Disease | Overactive Thyroid | MedlinePlus
    https://medlineplus.gov/hyperthyroidism.html
    Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. […] If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help. […] If hyperthyroidism isn’t treated, it can cause some serious health problems, including: An irregular heartbeat that can lead to blood clots, stroke, heart failure, and other heart problems. […] Almost everyone who has radioactive iodine treatment later develops hypothyroidism. This is because the thyroid hormone-producing cells have been destroyed. But hypothyroidism is easier to treat and causes fewer long-term health problems than hyperthyroidism.
  • #16 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #17 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #18 Hyperthyroidism | Graves’ Disease | Overactive Thyroid | MedlinePlus
    https://medlineplus.gov/hyperthyroidism.html
    Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. […] If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help. […] If hyperthyroidism isn’t treated, it can cause some serious health problems, including: An irregular heartbeat that can lead to blood clots, stroke, heart failure, and other heart problems. […] Almost everyone who has radioactive iodine treatment later develops hypothyroidism. This is because the thyroid hormone-producing cells have been destroyed. But hypothyroidism is easier to treat and causes fewer long-term health problems than hyperthyroidism.
  • #19 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    People with hyperthyroidism have a higher risk of developing further serious health conditions, such as cardiovascular and kidney disease. A persons life expectancy may depend on whether and how they develop those conditions. […] If an individual with the condition does not have serious complications, treatment is effective in managing symptoms and producing positive outcomes. In contrast, people who develop a rare complication known as thyroid storm have a death rate of about 16%. […] Data on the exact life expectancy of someone with hyperthyroidism are not available. That said, a 2017 study suggests that it is 3.1 to 3.5 years shorter than those without the condition. […] Evidence indicates that people with hyperthyroidism have a higher risk of noncommunicable conditions. As these illnesses are serious, they can affect life expectancy.
  • #20 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #21 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #22 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #23 Efficacy of I-131 Treatment Dosage for Hyperthyroidism With Current Institution Formula | Salam | Journal of Endocrinology and Metabolism
    https://jofem.org/index.php/jofem/article/view/874/284284630
    The results of this study testified to the therapeutic efficacy of the current institutions formula for I-131 treatment dosages in treating hyperthyroidism. […] The results also indicated the clinically significant impact of RAI therapy on post-ablation TSH, T3, and FT4 levels. […] The findings revealed an 83% success rate of RAI treatment defined by the achievement of euthyroid state and hypothyroidism. […] The absence of hyperthyroidism after I-131 treatment was further affirmed by questionable euthyroid state, subclinical hypothyroidism, questionable hypothyroidism, and suspected hypothyroidism. […] The treatment failure rate of 17% was, however, indicated by the reconfirmation of hyperthyroidism in 15 patients. […] In addition, a low number (i.e., 9%) of patients with hyperthyroidism required repeat I-131 treatment dosages to achieve a hypothyroid or euthyroid state.
  • #24 Efficacy of I-131 Treatment Dosage for Hyperthyroidism With Current Institution Formula | Salam | Journal of Endocrinology and Metabolism
    https://jofem.org/index.php/jofem/article/view/874/284284630
    The results, therefore, strongly advocated the therapeutic efficacy of the empirically derived I-131 institution formula in patients with hyperthyroidism and related complications. […] The findings of this study indicated an 83% RAI treatment success rate and the requirement of a second treatment session in 9% of patients with hyperthyroidism. […] The majority (i.e., 70.8%) of successfully treated patients were diagnosed with hypothyroidism followed by 6.7% who achieved a euthyroid status.
  • #25 Efficacy of I-131 Treatment Dosage for Hyperthyroidism With Current Institution Formula | Salam | Journal of Endocrinology and Metabolism
    https://jofem.org/index.php/jofem/article/view/874/284284630
    The results, therefore, strongly advocated the therapeutic efficacy of the empirically derived I-131 institution formula in patients with hyperthyroidism and related complications. […] The findings of this study indicated an 83% RAI treatment success rate and the requirement of a second treatment session in 9% of patients with hyperthyroidism. […] The majority (i.e., 70.8%) of successfully treated patients were diagnosed with hypothyroidism followed by 6.7% who achieved a euthyroid status.
  • #26 Hyperthyroidism | Graves’ Disease | Overactive Thyroid | MedlinePlus
    https://medlineplus.gov/hyperthyroidism.html
    Hyperthyroidism, or overactive thyroid, happens when your thyroid gland makes more thyroid hormones than your body needs. […] If not treated, hyperthyroidism can cause serious problems with your heart, bones, muscles, menstrual cycle, and fertility. But there are treatments that can help. […] If hyperthyroidism isn’t treated, it can cause some serious health problems, including: An irregular heartbeat that can lead to blood clots, stroke, heart failure, and other heart problems. […] Almost everyone who has radioactive iodine treatment later develops hypothyroidism. This is because the thyroid hormone-producing cells have been destroyed. But hypothyroidism is easier to treat and causes fewer long-term health problems than hyperthyroidism.
  • #27 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #28
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    Graves disease (GD) is the commonest cause of hyperthyroidism and has a strong female preponderance. […] This review supports the inheritance of GD as a complex genetic trait, with a growing number of more than 80 susceptibility loci identified so far. […] A key question given the large 60-80% genetic contribution to disease susceptibility is what constitutes the remaining non-genetic or potential precipitating factors. […] The phenotypic spectrum of GD is broad with patients exhibiting diverse clinical features and differing in biochemical severity. Several studies have demonstrated robust associations between specific clinical and biochemical factors and outcome in GD following withdrawal of antithyroid drugs (ATD), and have also identified prognostically relevant genetic associations.
  • #29 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #30 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #31 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #32
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    Graves disease (GD) is the commonest cause of hyperthyroidism and has a strong female preponderance. […] This review supports the inheritance of GD as a complex genetic trait, with a growing number of more than 80 susceptibility loci identified so far. […] A key question given the large 60-80% genetic contribution to disease susceptibility is what constitutes the remaining non-genetic or potential precipitating factors. […] The phenotypic spectrum of GD is broad with patients exhibiting diverse clinical features and differing in biochemical severity. Several studies have demonstrated robust associations between specific clinical and biochemical factors and outcome in GD following withdrawal of antithyroid drugs (ATD), and have also identified prognostically relevant genetic associations.
  • #33
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    Examining the association of genetic loci and clinical phenotype may not only provide mechanistic insight into the pathogenesis of GD, but also promote precision medicine by enabling the prediction of an individuals risk of relapse and their likely response to different therapeutic approaches. […] Several of the genetic variants associated with particular clinical/biochemical phenotypes have also been independently associated with an increased risk of GD reoccurrence, albeit inconsistently across different study populations. […] Identifying genetic variants that are associated with both clinical phenotype and prognosis may be clinically valuable to recognise patients at higher risk of relapse, and may help elucidate mechanistic insight into the functional impacts of genetic variation in GD.
  • #34
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    The addition of genetic risk alleles at HLA (DRB1-03, DQA1-05, DQB1-02) and PTPN22 (rs2476601) to form the GREAT+ score, demonstrated an improved predictive value for relapse when compared to clinical factors alone. […] Genotyping of GD patients may have significant translational potential by enabling a personalised treatment plan and the future implementation of novel immunomodulatory therapies for appropriate patients.
  • #35
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    The addition of genetic risk alleles at HLA (DRB1-03, DQA1-05, DQB1-02) and PTPN22 (rs2476601) to form the GREAT+ score, demonstrated an improved predictive value for relapse when compared to clinical factors alone. […] Genotyping of GD patients may have significant translational potential by enabling a personalised treatment plan and the future implementation of novel immunomodulatory therapies for appropriate patients.
  • #36 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Hyperthyroidism from toxic multinodular goiter and toxic adenoma is permanent and usually occurs in adults. After normalization of thyroid function with antithyroid medications, radioactive iodine ablation usually is recommended as the definitive therapy. Long-term, high-dose antithyroid medication is not recommended. Toxic multinodular goiters and toxic adenomas probably will continue to grow slowly in size during antithyroid pharmacotherapy. […] Generally, the thyrotoxic areas are ablated, and patients may remain euthyroid. Those who become hypothyroid after radioactive iodine therapy are easily maintained on thyroid hormone replacement therapy, with T4 taken once daily. […] Patients with Graves disease may become hypothyroid in the natural course of their disease, regardless of whether treatment involves radioactive iodine or surgery. Eye disease may develop at a time distant from the initial diagnosis and therapy. Generally, after the diagnosis, the ophthalmopathy slowly improves over years.
  • #37 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Hyperthyroidism from toxic multinodular goiter and toxic adenoma is permanent and usually occurs in adults. After normalization of thyroid function with antithyroid medications, radioactive iodine ablation usually is recommended as the definitive therapy. Long-term, high-dose antithyroid medication is not recommended. Toxic multinodular goiters and toxic adenomas probably will continue to grow slowly in size during antithyroid pharmacotherapy. […] Generally, the thyrotoxic areas are ablated, and patients may remain euthyroid. Those who become hypothyroid after radioactive iodine therapy are easily maintained on thyroid hormone replacement therapy, with T4 taken once daily. […] Patients with Graves disease may become hypothyroid in the natural course of their disease, regardless of whether treatment involves radioactive iodine or surgery. Eye disease may develop at a time distant from the initial diagnosis and therapy. Generally, after the diagnosis, the ophthalmopathy slowly improves over years.
  • #38 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #39 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #40 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #41 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #42 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #43 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #44 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #45 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Hyperthyroidism from toxic multinodular goiter and toxic adenoma is permanent and usually occurs in adults. After normalization of thyroid function with antithyroid medications, radioactive iodine ablation usually is recommended as the definitive therapy. Long-term, high-dose antithyroid medication is not recommended. Toxic multinodular goiters and toxic adenomas probably will continue to grow slowly in size during antithyroid pharmacotherapy. […] Generally, the thyrotoxic areas are ablated, and patients may remain euthyroid. Those who become hypothyroid after radioactive iodine therapy are easily maintained on thyroid hormone replacement therapy, with T4 taken once daily. […] Patients with Graves disease may become hypothyroid in the natural course of their disease, regardless of whether treatment involves radioactive iodine or surgery. Eye disease may develop at a time distant from the initial diagnosis and therapy. Generally, after the diagnosis, the ophthalmopathy slowly improves over years.
  • #46 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #47 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #48 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #49 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Cancer is the second most common cause of death worldwide. It is currently debated whether thyroid dysfunction is a modifiable cancer risk factor. Our aim was to evaluate the risk of cancer in patients with hyperthyroidism. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population.
  • #50 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #51 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    An older 2016 study reports that individuals with hyperthyroidism have a higher risk of death from all causes, with heart failure as the main cardiovascular cause. […] Hyperthyroidism due to Graves disease has overall positive outcomes that stem from the effectiveness of treatment for symptom management. Although Graves disease has no cure, medications can manage thyroid levels in almost all cases. […] The life expectancy of those with hyperthyroidism is generally favorable due to effective treatments. […] However, people with the condition have a higher risk of developing conditions such as cardiovascular disease or chronic kidney disease, particularly if they do not seek treatment. Any of these can negatively affect the outlook. […] They also are at risk of experiencing a rare complication known as thyroid storm, life threatening medical event. If someone experiences symptoms such as high fever, fast heartbeat, and delirium they should seek immediate medical attention.
  • #52 Hyperthyroidism (Overactive Thyroid): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/14129-hyperthyroidism
    Hyperthyroidism is a treatable condition. Most people do well with treatment. While some forms of treatment require you to take medication for the rest of your life, this will help keep your thyroid hormone levels in a healthy range. […] Untreated hyperthyroidism caused by Graves disease may get worse over time and cause complications, like Graves eye disease (Graves ophthalmopathy). If you have Graves disease, ask your healthcare provider how you can best manage the condition. […] Complications from untreated or undertreated hyperthyroidism include: Atrial fibrillation (Afib). Congestive heart failure. Infertility. Ischemic stroke. Osteoporosis. […] A rare and life-threatening complication of hyperthyroidism is thyroid storm (thyroid crisis or thyrotoxic crisis). It happens when your thyroid makes and releases a large amount of thyroid hormone in a short amount of time. Its an emergency that requires immediate medical attention. […] Untreated or inadequately treated hyperthyroidism can cause thyroid storm. Stressors like infection, injury or surgery may trigger it.
  • #53 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Overall, irrespective of cause of hyperthyroidism and location of cancer, hyperthyroid patients had an increased risk of cancer (SHR: 1.13; 95% CI: 1.12-1.16). […] After adjusting for pre-existing morbidity, patients with hyperthyroidism (SHR: 1.16; 95% CI: 1.14-1.18), GD (SHR: 1.08; 95% CI: 1.05-1.11), and TNG (SHR: 1.19; 95% CI: 1.16-1.23) had an increased risk of cancer. […] In conclusion, this nationwide register-based data demonstrated a 12% increased risk of cancer in a large cohort of hyperthyroid patients. The risk depended on the type of cancer, with increased SHRs for prostate, breast, and lung cancer but not for colorectal cancer. Similar results were found when stratifying for cause of hyperthyroidism. Although the validity of our results is supported by the size of the study it remains to be proven that hyperthyroidism is a pro-cancerogenic condition.
  • #54 Hyperthyroidism and Thyrotoxicosis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/121865-overview
    Thyroid hormone excess causes left ventricular thickening, which is associated with an increased risk of heart failure and cardiac-related death. Thyrotoxicosis has been associated with dilated cardiomyopathy, right heart failure with pulmonary hypertension, and diastolic dysfunction and atrial fibrillation. […] An increase in the rate of bone resorption occurs. Bone loss, measured by bone mineral densitometry, can be seen in severe hyperthyroidism at all ages and in both sexes. In mild subclinical disease, however, bone loss has been convincingly shown only in postmenopausal women. […] A study by Zhyzhneuskaya et al of patients with subclinical hyperthyroidism due to Graves disease suggested that approximately one third will progress to overt hyperthyroidism, about one third will develop normalized thyroid function, and just under one third will remain in a state of subclinical hyperthyroidism. (One person in the study became hypothyroid.) Multivariate regression analysis indicated that risk of progression to overt hypothyroidism is greater in patients with older age or a positive antithyroid peroxidase antibody status. The study included 44 patients, with follow-up lasting at least 12 months.
  • #55
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    Examining the association of genetic loci and clinical phenotype may not only provide mechanistic insight into the pathogenesis of GD, but also promote precision medicine by enabling the prediction of an individuals risk of relapse and their likely response to different therapeutic approaches. […] Several of the genetic variants associated with particular clinical/biochemical phenotypes have also been independently associated with an increased risk of GD reoccurrence, albeit inconsistently across different study populations. […] Identifying genetic variants that are associated with both clinical phenotype and prognosis may be clinically valuable to recognise patients at higher risk of relapse, and may help elucidate mechanistic insight into the functional impacts of genetic variation in GD.
  • #56
    https://link.springer.com/article/10.1007/s11154-023-09848-8
    The addition of genetic risk alleles at HLA (DRB1-03, DQA1-05, DQB1-02) and PTPN22 (rs2476601) to form the GREAT+ score, demonstrated an improved predictive value for relapse when compared to clinical factors alone. […] Genotyping of GD patients may have significant translational potential by enabling a personalised treatment plan and the future implementation of novel immunomodulatory therapies for appropriate patients.
  • #57 Hyperthyroidism life expectancy
    https://www.medicalnewstoday.com/articles/hyperthyroidism-life-expectancy
    People with hyperthyroidism have a higher risk of developing further serious health conditions, such as cardiovascular and kidney disease. A persons life expectancy may depend on whether and how they develop those conditions. […] If an individual with the condition does not have serious complications, treatment is effective in managing symptoms and producing positive outcomes. In contrast, people who develop a rare complication known as thyroid storm have a death rate of about 16%. […] Data on the exact life expectancy of someone with hyperthyroidism are not available. That said, a 2017 study suggests that it is 3.1 to 3.5 years shorter than those without the condition. […] Evidence indicates that people with hyperthyroidism have a higher risk of noncommunicable conditions. As these illnesses are serious, they can affect life expectancy.
  • #58 Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11046354/
    Cancer is the second most common cause of death worldwide. It is currently debated whether thyroid dysfunction is a modifiable cancer risk factor. Our aim was to evaluate the risk of cancer in patients with hyperthyroidism. […] Hyperthyroidism was associated with increased all-cause cancer risk (sub-distribution hazard ratio (SHR): 1.12; 95% CI: 1.10-1.14), as well as an increased risk of breast (SHR: 1.07; 95% CI: 1.02-1.13), lung (SHR: 1.20; 95% CI: 1.16-1.26), and prostate cancer (SHR: 1.10; 95% CI: 1.02-1.19), but not colorectal cancer (SHR: 1.04; 95% CI: 0.99-1.09). […] In this register-based study, patients with hyperthyroidism had an increased risk of cancer, in particular lung, prostate, and breast cancer. Whether a causal link exists remains to be proven. […] A total of 17,654 (18.5%) hyperthyroid individuals were diagnosed with cancer, compared to 59,977 (16.5%) individuals in the reference population.